Genelux (GNLX) Change in Cash (2022 - 2026)
Genelux (GNLX) recorded quarterly Change in Cash of $3.9 million in Q1 2026, up 514.66% quarter-over-quarter from $641000.0 in Q4 2025, and down 48.44% on a YoY basis from $7.6 million in Q1 2025.
Genelux (GNLX) Change in Cash (2022 - 2026) Analysis & Trends
Genelux's Change in Cash history runs 5 years deep, the most recent figure standing at $3.9 million for Q1 2026.
- In Q1 2026, Change in Cash fell 48.44% year-over-year to $3.9 million; the TTM figure through Mar 2026 stood at -$6.9 million (down 157.09% YoY), while the FY2025 annual figure was -$3.2 million, down 278.9% from the prior year.
- Change in Cash was $3.9 million for Q1 2026 at Genelux, up from $641000.0 in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $16.8 million in Q2 2023 to a low of -$20.5 million in Q4 2023.
- Historically, Change in Cash has averaged $705533.3 across 5 years, with a median of $2.5 million in 2024.
- Biggest YoY gain for Change in Cash was 270.93% in 2023; the steepest drop was 2001.85% in 2023.
- A 5-year view of Change in Cash shows it stood at -$973000.0 in 2022, then plunged by 2001.85% to -$20.5 million in 2023, then surged by 112.04% to $2.5 million in 2024, then sank by 73.97% to $641000.0 in 2025, then jumped by 514.66% to $3.9 million in 2026.
- The last three Change in Cash figures came in at $3.9 million (Q1 2026), $641000.0 (Q4 2025), and -$1.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -45.97 Mn |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - | 3.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.94 Mn |
| Dec 31, 2025 | 641,000.00 |
| Sep 30, 2025 | -1.85 Mn |
| Jun 30, 2025 | -9.66 Mn |
| Mar 31, 2025 | 7.64 Mn |
| Dec 31, 2024 | 2.46 Mn |
| Sep 30, 2024 | -1.76 Mn |
| Jun 30, 2024 | 3.80 Mn |
| Mar 31, 2024 | -5.36 Mn |
| Dec 31, 2023 | -20.45 Mn |
| Sep 30, 2023 | 2.73 Mn |
| Jun 30, 2023 | 16.80 Mn |
| Mar 31, 2023 | 9.94 Mn |
| Dec 31, 2022 | -973,000.00 |
| Mar 31, 2022 | 2.68 Mn |